Neoen Sa Stock Performance

NOSPF Stock  USD 42.00  8.00  23.53%   
Neoen SA has a performance score of 15 on a scale of 0 to 100. The company secures a Beta (Market Risk) of 0.0374, which conveys not very significant fluctuations relative to the market. As returns on the market increase, Neoen SA's returns are expected to increase less than the market. However, during the bear market, the loss of holding Neoen SA is expected to be smaller as well. Neoen SA right now secures a risk of 0.41%. Please verify Neoen SA jensen alpha, accumulation distribution, as well as the relationship between the Accumulation Distribution and market facilitation index , to decide if Neoen SA will be following its current price movements.

Risk-Adjusted Performance

15 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Neoen SA are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable basic indicators, Neoen SA is not utilizing all of its potentials. The recent stock price disturbance, may contribute to mid-run losses for the stockholders. ...more

Actual Historical Performance (%)

Year To Date Return
23.53
Ten Year Return
62.79
All Time Return
62.79
Quick Ratio1.36
Fifty Two Week Low31.60
Fifty Two Week High81.00
  

Neoen SA Relative Risk vs. Return Landscape

If you would invest  3,985  in Neoen SA on September 1, 2024 and sell it today you would earn a total of  215.00  from holding Neoen SA or generate 5.4% return on investment over 90 days. Neoen SA is currently producing 0.083% returns and takes up 0.4145% volatility of returns over 90 trading days. Put another way, 3% of traded otc stocks are less volatile than Neoen, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days horizon Neoen SA is expected to generate 1.81 times less return on investment than the market. But when comparing it to its historical volatility, the company is 1.81 times less risky than the market. It trades about 0.2 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.2 of returns per unit of risk over similar time horizon.

Neoen SA Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Neoen SA's investment risk. Standard deviation is the most common way to measure market volatility of otc stocks, such as Neoen SA, and traders can use it to determine the average amount a Neoen SA's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.2002

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashNOSPFAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 0.41
  actual daily
3
97% of assets are more volatile

Expected Return

 0.08
  actual daily
1
99% of assets have higher returns

Risk-Adjusted Return

 0.2
  actual daily
15
85% of assets perform better
Based on monthly moving average Neoen SA is performing at about 15% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Neoen SA by adding it to a well-diversified portfolio.

Neoen SA Fundamentals Growth

Neoen OTC Stock prices reflect investors' perceptions of the future prospects and financial health of Neoen SA, and Neoen SA fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Neoen OTC Stock performance.

About Neoen SA Performance

By analyzing Neoen SA's fundamental ratios, stakeholders can gain valuable insights into Neoen SA's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Neoen SA has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Neoen SA has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Neoen S.A., an independent renewable energy production company, engages in the design, development, finance, construction project management, and operation of renewable energy power plants. Neoen S.A. was founded in 2008 and is headquartered in Paris, France. Neoen Spa is traded on OTC Exchange in the United States.

Things to note about Neoen SA performance evaluation

Checking the ongoing alerts about Neoen SA for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for Neoen SA help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Neoen SA has high likelihood to experience some financial distress in the next 2 years
The company reported the revenue of 306.5 M. Net Loss for the year was (13.6 M) with profit before overhead, payroll, taxes, and interest of 279 M.
About 48.0% of the company outstanding shares are owned by corporate insiders
Latest headline from news.google.com: Minerals Technologies Dividend Payout Ratio 0.07 - GuruFocus.com
Evaluating Neoen SA's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Neoen SA's otc stock performance include:
  • Analyzing Neoen SA's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Neoen SA's stock is overvalued or undervalued compared to its peers.
  • Examining Neoen SA's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Neoen SA's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Neoen SA's management team can help you assess the OTC Stock's leadership.
  • Pay attention to analyst opinions and ratings of Neoen SA's otc stock. These opinions can provide insight into Neoen SA's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Neoen SA's otc stock performance is not an exact science, and many factors can impact Neoen SA's otc stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for Neoen OTC Stock analysis

When running Neoen SA's price analysis, check to measure Neoen SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neoen SA is operating at the current time. Most of Neoen SA's value examination focuses on studying past and present price action to predict the probability of Neoen SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neoen SA's price. Additionally, you may evaluate how the addition of Neoen SA to your portfolios can decrease your overall portfolio volatility.
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Bonds Directory
Find actively traded corporate debentures issued by US companies